Medicis (NYSE: MRX) today announced the U.S. FDA has approved its premarket approval application supplement, based ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE